Evidence map›Paper›PMID 40260971›Full record

ArticleProtein science : a publication of the Protein Society2025

Fine-tuning the yeast GAL10 promoter and growth conditions for efficient recombinant membrane protein production and purification.

Rebecca Moussa, François Gellé, Sandrine Masscheleyn, Alexandre Pozza, Christel Le Bon, Karine Moncoq, Françoise Bonneté, Bruno Miroux

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rebecca MoussaCNRS, Biochimie des protéines membranaires, UMR7099, Institut de Biologie Physico-Chimique, Université Paris Cité, Paris, France.
François GelléCNRS, Biochimie des protéines membranaires, UMR7099, Institut de Biologie Physico-Chimique, Université Paris Cité, Paris, France.
Sandrine MasscheleynCNRS, Biochimie des protéines membranaires, UMR7099, Institut de Biologie Physico-Chimique, Université Paris Cité, Paris, France.
Alexandre PozzaCNRS, Biochimie des protéines membranaires, UMR7099, Institut de Biologie Physico-Chimique, Université Paris Cité, Paris, France.
Christel Le BonCNRS, Biochimie des protéines membranaires, UMR7099, Institut de Biologie Physico-Chimique, Université Paris Cité, Paris, France.
Karine MoncoqCNRS, Biochimie des protéines membranaires, UMR7099, Institut de Biologie Physico-Chimique, Université Paris Cité, Paris, France.
Françoise BonnetéCNRS, Biochimie des protéines membranaires, UMR7099, Institut de Biologie Physico-Chimique, Université Paris Cité, Paris, France.
Bruno MirouxCNRS, Biochimie des protéines membranaires, UMR7099, Institut de Biologie Physico-Chimique, Université Paris Cité, Paris, France.ORCID 0000-0002-3066-4700

Funding

Agence Nationale de la Recherche CACSICE (ANR-11-EQPX-0008)Agence Nationale de la Recherche LABEX DYNAMO (ANR-11-LABX 0011)Agence Nationale de la Recherche Qlife ANR-17-CONV-0005CNRS-MITI interdisciplinary program "Modélisation du Vivant" 2021 & 2022 and Tremplin@INP 2021
6 · The paper itself

Abstract

One of the most common issues in producing membrane proteins in heterologous expression systems is the low yield of purified protein. The solubilization efficiency of the recombinant membrane protein from biological membranes is often the limiting step. Here, we study the effects of titration of the GAL10-CYC promoter of Saccharomyces cerevisiae, induction time, and culture media, on the rat mitochondrial uncoupling protein (UCP1) production and solubilization levels. We found that a maximum threshold of solubilized UCP1 (70%) is reached at 0.003% galactose concentration, independently of time, temperature, and detergent-to-protein ratio during solubilization. Supplementation with 0.1% amino acids of the S-lactate medium at induction resumes cell growth and recombinant protein production. The purified UCP1 protein (0.2 mg/L) is homogenous in DDM detergent and active after reconstitution in proteoliposomes. To extend the impact of our findings, we applied the same promoter titration to produce the GFP-AT7B human transporter and found an optimal galactose concentration of 0.0015%. The protein data bank analysis revealed that these galactose concentrations are 300 times lower than usual. We propose a novel strategy for the recombinant production of membrane proteins in the yeast S. cerevisiae, which unlocks the use of this inexpensive eukaryotic host for membrane protein production.

Indexed as

Membrane ProteinsPromoter Regions, GeneticRecombinant ProteinsSaccharomyces cerevisiaeUncoupling Protein 1AnimalsGalactoseHumansRatsSaccharomyces cerevisiae ProteinsGalactoseMembrane ProteinsRecombinant ProteinsSaccharomyces cerevisiae ProteinsUncoupling Protein 1detergentgalactose promotermembrane protein productionS. cerevisiaesolubilization

Identifiers

PMID40260971
PMCPMC12012841

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.